Literature DB >> 32311089

Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature.

Camilla Chello1, Giorgia Carnicelli1, Alvise Sernicola1, Nazareno Gagliostro1, Giovanni Paolino1,2, Marco Di Fraia1, Valentina Faina1, Rovena Muharremi1, Teresa Grieco1.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a chronic relapsing eczematous dermatitis typically affecting young patients in a percentage from 15 to 20%; although it typically affects young people and adults, recent papers highlighted the emerging of the disease in the elderly population.
METHODS: The aim of the study was to identify the clinical criteria and allergic sensitization that may be able to support physicians and dermatologists in making a correct diagnosis of AD in the elderly. The second aim of this study was to investigate the incidence, the main features, the gender prevalence, the immunological profile, and comorbidities characterizing patients older than 65 years affected by AD.
RESULTS: Based on clinical and serological patterns, different phenotypes of AD were identified: generalized AD (55%) characterized by eczematous lesions involving typical areas of the body or prurigo nodularis-like AD; chronic eczematous hand dermatitis (23%); face and neck involvement (9%); and nummular eczema (13%). Skin prick tests revealed a positivity for aeroallergens in 49.6% of patients, most of them being polysensitized (55%). Additionally, food skin prick tests were positive in 25% of patients. Most of the patients reported comorbidities, particularly IgE-mediated diseases, such as seasonal rhino-conjunctivitis, asthma, and chronic obstructive pulmonary disease. Gastrointestinal symptoms such as meteorism, dyspepsia, cramps/abdominal pain, and diarrhea/constipation, were observed in 35% of patients consequent to food allergy.
CONCLUSION: In our study, we suggest clinical and serological criteria that may be able to guide in the diagnosis of AD in Caucasian elderly, and to design an appropriate treatment according to the current standard protocol.
© 2020 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32311089     DOI: 10.1111/ijd.14891

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.

Authors:  Takeshi Nakahara; Makiko Kido-Nakahara; Daisuke Onozuka; Sawako Sakai; Tomoko Hirose; Nobutoshi Take; Akiko Sugiyama; Kayo Harada; Gaku Tsuji; Satoko Kikuchi; Futoshi Kohda
Journal:  Acta Derm Venereol       Date:  2021-11-10       Impact factor: 3.875

2.  Self-reported allergies in Russia and impact on skin.

Authors:  Sophie Seité; Charles Taieb; Tamara Lazic Strugar; Peter Lio; Elena E Bobrova
Journal:  SAGE Open Med       Date:  2020-09-12

3.  Nomenclature and clinical phenotypes of atopic dermatitis.

Authors:  Giampiero Girolomoni; Marjolein de Bruin-Weller; Valeria Aoki; Kenji Kabashima; Mette Deleuran; Luis Puig; Ashish Bansal; Ana B Rossi
Journal:  Ther Adv Chronic Dis       Date:  2021-03-26       Impact factor: 5.091

4.  Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.

Authors:  Teresa Grieco; Patrizia Maddalena; Alvise Sernicola; Rovena Muharremi; Stefania Basili; Domenico Alvaro; Roberto Cangemi; Alfredo Rossi; Giovanni Pellacani
Journal:  Dermatol Ther       Date:  2021-10-13       Impact factor: 3.858

Review 5.  Skin Dialogues in Atopic Dermatitis.

Authors:  Elena Porumb-Andrese; Claudia Florida Costea; Andrei Cucu; Gabriela Rusu-Zota; Daciana Elena Braisteanu; Vlad Porumb; Mihaela Monica Scutariu; Alexandra Maria Dorobanțu; Ramona Gabriela Ursu
Journal:  Diagnostics (Basel)       Date:  2022-08-04

6.  The Role of Oxidative Stress in Atopic Dermatitis and Chronic Urticaria.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marek Biesiadecki; Agnieszka Bożek; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-08-16

Review 7.  The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis.

Authors:  Georgia Pappa; Dimitrios Sgouros; Konstantinos Theodoropoulos; Antonios Kanelleas; Evangelia Bozi; Stamatios Gregoriou; Konstantinos Krasagakis; Alexander C Katoulis
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

Review 8.  Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic.

Authors:  Isabelle Haddad; Kathia Kozman; Abdul-Ghani Kibbi
Journal:  Front Allergy       Date:  2022-10-04

Review 9.  Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.

Authors:  Karol Kołkowski; Magdalena Trzeciak; Małgorzata Sokołowska-Wojdyło
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.